Please note that masks are still required in all Blue Ridge Cancer Care offices regardless of vaccination status.
Learn more about this and other current Covid-19 policies.

Research Institute

A Phase 2 study of Sacituzumab Govitecan in Solid Tumors

A Phase 2 Open Label Study of Sacituzumab Govitecan (IMMU-132) in Subjects with Metastatic Solid Tumors

Disease Types: Solid Tumors

Available at: AlleghanyBlacksburgRoanokeSalemWytheville

A Phase 2 Open Label Study of Sacituzumab Govitecan (IMMU-132) in Subjects with Metastatic Solid Tumors

For more information:

https://clinicaltrials.gov/ct2/show/NCT03964727?term=03964727&draw=2&rank=1